Anna Wickman

914 total citations
27 papers, 736 citations indexed

About

Anna Wickman is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Anna Wickman has authored 27 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 10 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Physiology. Recurrent topics in Anna Wickman's work include Renin-Angiotensin System Studies (8 papers), Growth Hormone and Insulin-like Growth Factors (7 papers) and Adipose Tissue and Metabolism (6 papers). Anna Wickman is often cited by papers focused on Renin-Angiotensin System Studies (8 papers), Growth Hormone and Insulin-like Growth Factors (7 papers) and Adipose Tissue and Metabolism (6 papers). Anna Wickman collaborates with scholars based in Sweden, Canada and Australia. Anna Wickman's co-authors include Göran Bergström, Birgitta Sundelin, Michael A. Adams, Peter Friberg, Sven‐Olof Bohman, Helena Gustafsson, A. Bobik, Holger Nilsson, Vincent Fridén and Jörgen Isgaard and has published in prestigious journals such as Diabetes, Kidney International and Hypertension.

In The Last Decade

Anna Wickman

27 papers receiving 725 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Wickman Sweden	16	351	277	231	135	127	27	736
Liliya M. Yamaleyeva United States	18	240 0.7×	247 0.9×	155 0.7×	139 1.0×	78 0.6×	38	833
Tadashi Konoshita Japan	16	368 1.0×	283 1.0×	193 0.8×	91 0.7×	58 0.5×	49	744
Karoline von Websky Germany	16	149 0.4×	339 1.2×	164 0.7×	52 0.4×	92 0.7×	25	793
Lars Rothermund Germany	14	280 0.8×	115 0.4×	134 0.6×	70 0.5×	318 2.5×	27	692
Allan F. Moore United States	10	393 1.1×	359 1.3×	328 1.4×	37 0.3×	68 0.5×	16	737
O. Costerousse France	10	674 1.9×	417 1.5×	183 0.8×	32 0.2×	74 0.6×	16	906
Tatsuya Narita Japan	11	284 0.8×	237 0.9×	269 1.2×	44 0.3×	38 0.3×	23	569
Daniel P. K. Ng Singapore	13	141 0.4×	190 0.7×	301 1.3×	35 0.3×	61 0.5×	20	766
Keita Hiragushi Japan	8	181 0.5×	117 0.4×	233 1.0×	35 0.3×	162 1.3×	11	689
R Dechend Germany	7	205 0.6×	105 0.4×	135 0.6×	24 0.2×	52 0.4×	11	570

Countries citing papers authored by Anna Wickman

Since Specialization

Citations

This map shows the geographic impact of Anna Wickman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Wickman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Wickman more than expected).

Fields of papers citing papers by Anna Wickman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Wickman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Wickman. The network helps show where Anna Wickman may publish in the future.

Co-authorship network of co-authors of Anna Wickman

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Wickman. A scholar is included among the top collaborators of Anna Wickman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Wickman. Anna Wickman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ståhle, Mia, Johanna M. U. Silvola, Sanna Hellberg, et al.. (2020). Therapeutic Antibody Against Phosphorylcholine Preserves Coronary Function and Attenuates Vascular 18F-FDG Uptake in Atherosclerotic Mice. JACC Basic to Translational Science. 5(4). 360–373. 10 indexed citations

Fridén, Vincent, Aida Muslimović, Sven‐Erik Ricksten, et al.. (2017). Clearance of cardiac troponin T with and without kidney function. Clinical Biochemistry. 50(9). 468–474. 102 indexed citations

Pálsdóttir, Vilborg, Anna Wickman, Niklas Andersson, et al.. (2010). Postnatal deficiency of essential fatty acids in mice results in resistance to diet-induced obesity and low plasma insulin during adulthood. Prostaglandins Leukotrienes and Essential Fatty Acids. 84(3-4). 85–92. 9 indexed citations

Andersson, Irene J., Maria E. Johansson, Anna Wickman, et al.. (2006). Endothelial dysfunction in growth hormone transgenic mice. Clinical Science. 110(2). 217–225. 24 indexed citations

Johansson, Maria E., Anna Wickman, Ole Skøtt, Li‐Ming Gan, & Göran Bergström. (2006). Blood pressure is the major driving force for plaque formation in aortic-constricted ApoE−/− mice. Journal of Hypertension. 24(10). 2001–2008. 10 indexed citations

Nyström, Helena Filipsson, Per Henrik Lindblom, Anna Wickman, et al.. (2006). Platelet-derived growth factor B retention is essential for development of normal structure and function of conduit vessels and capillaries☆. Cardiovascular Research. 71(3). 557–565. 32 indexed citations

Johansson, Maria E., Anna Wickman, Sharyn M. Fitzgerald, Li-Ming Gan, & Göran Bergström. (2005). Angiotensin II, type 2 receptor is not involved in the angiotensin II-mediated pro-atherogenic process in ApoE−/− mice. Journal of Hypertension. 23(8). 1541–1549. 27 indexed citations

Nyström, Henrik, et al.. (2005). Short-term administration of growth hormone (GH) lowers blood pressure by activating eNOS/nitric oxide (NO)-pathway in male hypophysectomized (Hx) rats. BMC Physiology. 5(1). 17–17. 11 indexed citations

Johansson, Maria E., et al.. (2005). Haemodynamically significant plaque formation and regional endothelial dysfunction in cholesterol-fed ApoE−/− mice. Clinical Science. 108(6). 531–538. 16 indexed citations

10.

Fitzgerald, Sharyn M., Li‐Ming Gan, Anna Wickman, & Göran Bergström. (2003). Cardiovascular and renal phenotyping of genetically modified mice: A challenge for traditional physiology. Clinical and Experimental Pharmacology and Physiology. 30(4). 207–216. 17 indexed citations

11.

Bergström, Göran, Inger Johansson, Anna Wickman, Li‐Ming Gan, & Christian Thorup. (2002). Brief losartan treatment in young spontaneously hypertensive rats abates long-term blood pressure elevation by effects on renal vascular structure. Journal of Hypertension. 20(7). 1413–1421. 32 indexed citations

12.

Wickman, Anna, I. H. Jonsdottir, Göran Bergström, & Lars O. Hedin. (2002). GH and IGF-I regulate the expression of endothelial nitric oxide synthase (eNOS) in cardiovascular tissues of hypophysectomized female rats. European Journal of Endocrinology. 147(4). 523–533. 36 indexed citations

13.

Wickman, Anna, et al.. (2001). Endothelial nitric oxide synthase protein is reduced in the renal medulla of two-kidney, one-clip hypertensive rats. Journal of Hypertension. 19(9). 1665–1673. 26 indexed citations

14.

Wickman, Anna, Jörgen Isgaard, Michael A. Adams, & Peter Friberg. (1999). Differential regulation of IGF-I, its receptor and GH receptor mRNAs in the right ventricle and caval vein in volume-loaded genetically hypertensive and normotensive rats. Journal of Endocrinology. 161(2). 263–271. 3 indexed citations

15.

Guron, Gregor, Birgitta Sundelin, Anna Wickman, & Peter Friberg. (1998). ANGIOTENSIN‐CONVERTING ENZYME INHIBITION IN PIGLETS INDUCES PERSISTENT RENAL ABNORMALITIES. Clinical and Experimental Pharmacology and Physiology. 25(2). 88–91. 22 indexed citations

16.

Friberg, Peter, et al.. (1998). Inhibited expression of insulin-like growth factor I mRNA and attenuated cardiac hypertrophy in volume overloaded hearts treated with difluoromethylornithine. Growth Hormone & IGF Research. 8(2). 159–165. 1 indexed citations

17.

Wickman, Anna, Jörgen Isgaard, Michael A. Adams, & Peter Friberg. (1997). Inhibition of nitric oxide in rats. Regulation of cardiovascular structure and expression of insulin-like growth factor I and its receptor messenger RNA. Journal of Hypertension. 15(7). 751–759. 8 indexed citations

18.

Wickman, Anna, Peter Friberg, Michael A. Adams, et al.. (1997). Induction of Growth Hormone Receptor and Insulin-Like Growth Factor-I mRNA in Aorta and Caval Vein During Hemodynamic Challenge. Hypertension. 29(1). 123–130. 22 indexed citations

19.

Wåhlander, Håkan, Morgan Sohtell, Anna Wickman, Annika Nilsson, & Peter Friberg. (1996). Therapeutic, But Not Low-Dose, Angiotensin-Converting Enzyme Inhibition Causes Regression of Cardiovascular Changes in Spontaneously Hypertensive Rats. Journal of Cardiovascular Pharmacology. 27(3). 327–334. 6 indexed citations

20.

Sundelin, Birgitta, Sven‐Olof Bohman, A. Bobik, et al.. (1994). Renin-angiotensin system in neonatal rats: Induction of a renal abnormality in response to ACE inhibition or angiotensin II antagonism. Kidney International. 45(2). 485–492. 176 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact